These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2403290)

  • 41. Clinical manifestations and leukocyte neurotoxic esterase and red blood cell and plasma acetylcholinesterase activities in swine following a single oral dose of tri-o-cresyl phosphate.
    Barrett DS; Oehme FW; Kruckenberg SM; Smith JE
    Vet Hum Toxicol; 1994 Apr; 36(2):103-9. PubMed ID: 8197706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN).
    Veronesi B; Padilla S; Blackmon K; Pope C
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):311-24. PubMed ID: 1994513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison.
    Chanda SM; Mortensen SR; Moser VC; Padilla S
    Fundam Appl Toxicol; 1997 Aug; 38(2):148-57. PubMed ID: 9299188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro deacetylation studies with isomeric acetamidobiphenyls using selective carboxylesterase inhibitors.
    Sertkaya NN; Gorrod JW
    Anticancer Res; 1988; 8(6):1345-50. PubMed ID: 3218967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absorption, distribution, excretion and metabolism of a single oral dose of [14C]tri-o-cresyl phosphate (TOCP) in the male rat.
    Abou-Donia MB; Nomeir AA; Bower JH; Makkawy HA
    Toxicology; 1990 Dec; 65(1-2):61-74. PubMed ID: 2274970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of tri-ortho-cresyl phosphate on hen nervous system.
    Biswas S; Biswas SK; Bhattacharyya AK
    Indian J Med Res; 1993 Apr; 98():96-101. PubMed ID: 8344740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro neurotoxic hazard characterization of different tricresyl phosphate (TCP) isomers and mixtures.
    Duarte DJ; Rutten JMM; van den Berg M; Westerink RHS
    Neurotoxicology; 2017 Mar; 59():222-230. PubMed ID: 26851706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Six-month daily treatment of sheep with neurotoxic organophosphorus compounds.
    Soliman SA; Svendsgaard D; Farmer JD; Curley A; Durham WF
    Toxicol Appl Pharmacol; 1983 Jul; 69(3):417-31. PubMed ID: 6192547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of a single oral dose of tri-o-cresyl phosphate on neurotoxic esterase and acetylcholinesterase activities in the central nervous system, erythrocytes and plasma.
    Barrett DS; Oehme FW
    Vet Hum Toxicol; 1994 Feb; 36(1):1-4. PubMed ID: 8154093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strain comparisons of DFP neurotoxicity in rats.
    Gordon CJ; MacPhail RC
    J Toxicol Environ Health; 1993 Mar; 38(3):257-71. PubMed ID: 8450557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Esterase activities and soman toxicity in developing rat.
    Sterri SH; Berge G; Fonnum F
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):136-40. PubMed ID: 4061089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tri-ortho-cresyl phosphate induced neurotarget esterase inhibition in brain and peripheral nerve effectively monitored by lymphocytes.
    Nanda S; Tapaswi PK
    Indian J Exp Biol; 1994 May; 32(5):356-9. PubMed ID: 7927531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of neurotoxic organophosphorus compounds in turkeys.
    Larsen C; Jortner BS; Ehrich M
    J Toxicol Environ Health; 1986; 17(4):365-74. PubMed ID: 3959118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed neuropathy and inhibition of soluble neuropathy target esterase following the administration of organophosphorus compounds to hens.
    Tian Y; Xie XK; Piao FY; Yamauchi T
    Tohoku J Exp Med; 1998 Jul; 185(3):161-71. PubMed ID: 9823777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of inhibition and activation of ali-esterase on the acute toxicity of organophosphates in rats].
    Jokanović M
    God Vojnomed Akad; 1986; 28():60-3. PubMed ID: 3482061
    [No Abstract]   [Full Text] [Related]  

  • 56. Electrophysiologic changes following treatment with organophosphorus-induced delayed neuropathy-producing agents in the adult hen.
    Robertson DG; Schwab BW; Sills RD; Richardson RJ; Anderson RJ
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):420-9. PubMed ID: 3564017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inactivation of atracurium in human and rat plasma.
    Nigrovic V; Pandya JB; Auen M; Wajskol A
    Anesth Analg; 1985 Nov; 64(11):1047-52. PubMed ID: 2932037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes.
    Fonnum F; Sterri SH; Aas P; Johnsen H
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S29-38. PubMed ID: 4092894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification and characterization of two rat liver microsomal carboxylesterases (hydrolase A and B).
    Morgan EW; Yan B; Greenway D; Petersen DR; Parkinson A
    Arch Biochem Biophys; 1994 Dec; 315(2):495-512. PubMed ID: 7986098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholinesterase and carboxylesterase activities in soman poisoned rats treated with bispyridinium mono-oximes HI-6 and HS-6.
    Sterri SH; Lyngaas S; Fonnum F
    Biochem Pharmacol; 1983 May; 32(10):1646-9. PubMed ID: 6860351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.